Navigation Links
Delcath Highlights Phase III Trial Results Presented at ASCO
Date:6/5/2010

turation via PHP has potential life-extending benefits as a treatment for patients suffering with terminal, metastatic disease in the liver.  Our rolling submission to the FDA is underway, and we are extremely excited by the future of this promising new treatment."

The data presented by Dr. Pingpank on June 5th are the result of the trial's Principal Investigator analysis and differ from results of the independent, blinded core lab analysis announced by Delcath on April 21, 2010.  

About Delcath Systems

Delcath Systems, Inc. is a development stage, specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers.  Delcath recently concluded a Phase III metastatic melanoma study, and the Company is currently conducting a multi-arm Phase II trial to treat other liver cancers. The Company has not yet received FDA or any foreign regulatory approval for commercial sale of its system.  For more information, please visit the Company's website at www.delcath.com.  

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
2. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
3. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
4. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
5. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
6. Delcath Systems Granted Third Orphan Drug Designation
7. Delcath Enters Agreement to Sell 869,565 Units
8. Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
9. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
10. Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  Having the right people at ... to accelerating business growth and achieving clinical and operational ... (AHA) Leadership Summit, July 20-22, 2014, in ... hospital executives and healthcare experts discussing how partnerships have ... , President & Chief Executive Officer of Cape Regional ...
(Date:7/23/2014)... , July 23, 2014 /PRNewswire/ - BioAmber Inc. ... company producing sustainable chemicals, today announced that the underwriters ... their option to purchase an additional 420,000 shares ... of $12.00 per share, less underwriting discounts and ... public offering of 2,800,000 shares of common stock, ...
(Date:7/23/2014)... KONG , July 23, 2014 China Cord Blood ... China,s leading provider of cord blood collection, laboratory ... Cordlife Group Limited ("Cordlife"), a multi-product healthcare company catering to the ... joined forces in assisting patients across the PRC, Singapore ... , India , the Philippines ...
(Date:7/23/2014)... July 23, 2014 Astra ... and comprehensive consultancy and pharma training services, and ... Safety (ACRES) , a non-profit integrating the expertise ... and maintain a global system for clinical trials, ... to improve the expertise of industry professionals through ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... Building the Merge Healthcare of tomorrow, as ... offshoring 150 jobs to a "more cost effective workforce" ... of the financially troubled medical imaging software company's workforce ... the competitive edge marks the centerpiece of a broader ...
... - TeraMedica , a medical informatics company, has ... the VisLite Information Manager , an ... , ,The product integrates and manages advanced and traditional ... records and health records. , ,It also uses open ...
... spend the most on research and development in the life ... University of Wisconsin-Madison ($764 million) is perennially among the ... the list is the Medical College of Wisconsin ... research centers. Next up is the University of Wisconsin-Milwaukee ...
Cached Biology Technology:Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Marshfield Clinic and UW combine to speed tech growth 2Marshfield Clinic and UW combine to speed tech growth 3Marshfield Clinic and UW combine to speed tech growth 4
(Date:7/23/2014)... grip is affecting more than the color of people,s lawns. ... heat-loving amoeba commonly found in warm freshwater bodies, such as ... warmer than usual this year. , A 9-year-old Kansas girl ... swimming in several area lakes. The amoeba enters the body ... brain. Nose plugs can lower the odds of this rare ...
(Date:7/23/2014)... commonly found in dead bodies and is used in ... to as the post mortem interval. A report of ... Tamil Nadu is provided for the first time based ... DNA barcoding. This study, significant in forensic investigations was ... . , Chrysomya megacephala is commonly found ...
(Date:7/23/2014)... around the world by 2050, according to one of ... Change (IPCC), may be advantageous to the physiology and ... of forage plants such as Stylosanthes capitata Vogel ... countries such as Brazil., The conclusion is from a ... Biology at the Ribeiro Preto Faculty of Philosophy, Sciences ...
Breaking Biology News(10 mins):Diseases of another kind 2Dead body feeding larvae useful in forensic investigations 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4
... Davis researchers in nanotechnology, chemistry and biology now have access ... in the world. The new Spectral Imaging Facility, opened this ... a laser scanning confocal microscope, the first commercial machine of ... Asylum Research of Santa Barbara and the confocal microscope system ...
... gained new insights into how neurons control growth ... that enable them to connect with their neighbors. ... which neurons form the signaling networks that constitute ... neuronal growth will help researchers better understand brain ...
... preliminary results from a study in Botswana, Harvard School ... HIV-1 subtype C in resource-poor settings, who receive antiretroviral ... the developed world. A fully supported health care delivery ... data published in November 2005 issue of the Journal ...
Cached Biology News:How the neuron sprouts its branches 2How the neuron sprouts its branches 3Largest computational biology simulation mimics life’s most essential nanomachine 2
Recombinant Mouse LIGHT/TNFSF14...
TAR DNA binding protein...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE)...
Biology Products: